Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-He Huang

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
American Journal of Physiology. Heart and Circulatory Physiology|April 10, 2007
Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combinationYumei Ye, Yu Lin, Regino Perez-Polo, et al.
Cardiovascular Drugs and Therapy|May 13, 2011
Heart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusionMing-He Huang, Yewen Wu, Vincent Nguyen, et al.
Circulation|August 16, 2006
Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the ratYochai Birnbaum, Yumei Ye, Yu Lin, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 13, 2005
Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2Shaul Atar, Yumei Ye, Yu Lin, et al.
Cardiovascular Drugs and Therapy|July 11, 2007
The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activationSaraswathy Manickavasagam, Yumei Ye, Yu Lin, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 21, 2007
Mediating delta-opioid-initiated heart protection via the beta2-adrenergic receptor: role of the intrinsic cardiac adrenergic cellMing-He Huang, Hui-Qun Wang, William R Roeske, et al.
European Journal of Clinical Pharmacology|January 28, 2014
Safety of combination therapy with milrinone and esmolol for heart protection during percutaneous coronary intervention in acute myocardial infarctionKian-Keong Poh, Xin Xu, Mark Y Chan, et al.
Cardiovascular Research|July 8, 2009
Reducing ischaemia/reperfusion injury through delta-opioid-regulated intrinsic cardiac adrenergic cells: adrenopeptidergic co-signallingMing-He Huang, Vincent Nguyen, Yewen Wu, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
American Journal of Physiology. Heart and Circulatory Physiology|April 10, 2007
Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combinationYumei Ye, Yu Lin, Regino Perez-Polo, et al.
Cardiovascular Drugs and Therapy|May 13, 2011
Heart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusionMing-He Huang, Yewen Wu, Vincent Nguyen, et al.
Circulation|August 16, 2006
Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the ratYochai Birnbaum, Yumei Ye, Yu Lin, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 13, 2005
Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2Shaul Atar, Yumei Ye, Yu Lin, et al.
Cardiovascular Drugs and Therapy|July 11, 2007
The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activationSaraswathy Manickavasagam, Yumei Ye, Yu Lin, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 21, 2007
Mediating delta-opioid-initiated heart protection via the beta2-adrenergic receptor: role of the intrinsic cardiac adrenergic cellMing-He Huang, Hui-Qun Wang, William R Roeske, et al.
European Journal of Clinical Pharmacology|January 28, 2014
Safety of combination therapy with milrinone and esmolol for heart protection during percutaneous coronary intervention in acute myocardial infarctionKian-Keong Poh, Xin Xu, Mark Y Chan, et al.
Cardiovascular Research|July 8, 2009
Reducing ischaemia/reperfusion injury through delta-opioid-regulated intrinsic cardiac adrenergic cells: adrenopeptidergic co-signallingMing-He Huang, Vincent Nguyen, Yewen Wu, et al.
Pageof 3